Efficacy of anti-VEGF agents in the treatment of elderly hepatocellular carcinoma: a systematic review

PURPOSE: We aimed to investigate the role of anti-vascular endothelial growth factor (VEGF) agents, including tyrosine-kinase inhibitors or monoclonal anti-bodies, in the treatment of elderly hepatocellular carcinoma (HCC) patients. MATERIALS AND METHODS: Databases from PubMed, Web of Science and ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaofei, Zhang, Daofu, Guan, Shan, Ye, Weiwei, Liu, Liwen, Lou, Lianqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696253/
https://www.ncbi.nlm.nih.gov/pubmed/29190987
http://dx.doi.org/10.18632/oncotarget.21452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696253/
https://www.ncbi.nlm.nih.gov/pubmed/29190987
http://dx.doi.org/10.18632/oncotarget.21452

Ejemplares similares